Disclosure of Possible Trial Termination to Participants of Interventional Clinical Trials

JAMA. 2023 Apr 4;329(13):1116-1117. doi: 10.1001/jama.2023.0875.
No abstract available

Plain language summary

This study evaluates a cross-section of interventional clinical trials registered on ClinicalTrials.gov with publicly available informed consent forms along with the proportion of trials that disclosed the possibility of trial termination.

MeSH terms

  • Clinical Trials as Topic*
  • Databases, Factual
  • Disclosure
  • Humans
  • Registries
  • Research Design*
  • Truth Disclosure*
  • Withholding Treatment